This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

CPHI Japan

Profile

Japan's largest pharmaceutical industry event, gathering approximately 30,000 people from 60 countries around the world.

Exhibition and seminars will be held simultaneously to support drug discovery, development and manufacturing, from small molecules to bio and regenerative medicine.

In 2024, approximately 30,000 pharmaceutical professionals from about 50 countries around the world will attend the exhibition to discuss pharmaceutical development and present the latest technologies.


CPHI aims to further grow as an event that supports new drug development and stable supply as a pharmaceutical development exhibition that provides one-stop services from drug discovery to manufacturing, and revitalizes the pharmaceutical industry. We will attract approximately 800 suppliers and hold an exhibition as a meeting place to discover the best partners to support the challenges of creating innovative new drugs from Japan and providing a stable supply, which is the goal of the Japanese pharmaceutical industry.


In addition, the conference and seminar programs that will present domestic and international regulations, markets, the latest technologies, etc. in the industry will be further enhanced, and approximately 250 sessions are expected to be held. We
hope that all pharmaceutical industry professionals will continue to use this exhibition to promote their business.

Contact